NFKB1 and chronic obstructive pulmonary disease: In chronic obstructive pulmonary disease, luteolin alleviates oxidative stress and inflammation via inhibition of NOX4‐mediated NF‐κB signaling pathway and levels of inflammation factors (Li, Wang, et al. 2023).